CEO Geoffrey Dow, PhD. ILADS presentation: 8-Aminoquinolines & Babesiosis – A Clinical Research and Safety Perspective
December 9, 2024
View Presentation 170.9 MB
CEO Geoff Dow Virtual Presentation to HC Wainwright Global Equity Conference
September 9, 2024